SU3327

CAS No. 40045-50-9

SU3327( —— )

Catalog No. M24361 CAS No. 40045-50-9

SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 85 In Stock
2MG 30 In Stock
5MG 56 In Stock
10MG 92 In Stock
25MG 174 In Stock
50MG 305 In Stock
100MG 462 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SU3327
  • Note
    Research use only, not for human use.
  • Brief Description
    SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
  • Description
    SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
  • In Vitro
    ——
  • In Vivo
    Animal Model:Male BKS.Cg-+Leprdb/+Leprdb/OlaHsd db/db mice (11-week-old ) injected with insulin Dosage:25 mg/kg Administration:Intraperitoneal injection Result:Resulted in a statistically significant reduction in blood glucose levels.
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    JNK|JNK-JIP interactions
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    40045-50-9
  • Formula Weight
    261.3
  • Molecular Formula
    C5H3N5O2S3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:62.5 mg/mL (239.19 mM; Need ultrasonic)
  • SMILES
    Nc1nnc(Sc2ncc([N+]([O-])=O)s2)s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.De SK, et al. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. J Med Chem. 2009 Apr 9;52(7):1943-52.
molnova catalog
related products
  • AS601245

    AS601245, an anti-Inflammatory JNK inhibitor, and Clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells .

  • IQ-1S

    A potent, highly specific JNK inhibitor with IC50 of 390, 360, and 87 nM for JNK1, JNK2, and JNK3, respectively.

  • AS601245.2TFA

    AS601245.2TFA is a cell-permeable Inhibitor of JNK (IC50s of 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively).